The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses.

Cheng, Hsiu-Chi; Kao, Ai-Wen; Chuang, Chiao-Hsiung; Sheu, Bor-Shyang

Cheng, Hsiu-Chi; Kao, Ai-Wen; Chuang, Chiao-Hsiung; Sheu, Bor-Shyang.

Affiliation

Cheng HC; Department of Internal Medicine and tlnstitute of Clinical Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.

Dig Dis Sci ; 50(7): 1194-201, 2005 Jul.

Article in En | MEDLINE | ID: mdl-16047459

Subject(s)

Anti-Ulcer Agents/administration & dosage; Enzyme Inhibitors/administration & dosage; Omeprazole/administration & dosage; Peptic Ulcer Hemorrhage/prevention & control; Aged; Anti-Ulcer Agents/therapeutic use; Creatine/blood; Dose-Response Relationship, Drug; Enzyme Inhibitors/therapeutic use; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic/complications; Logistic Models; Male; Middle Aged; Omeprazole/therapeutic use; Peptic Ulcer Hemorrhage/blood; Peptic Ulcer Hemorrhage/complications; Secondary Prevention; Serum Albumin/metabolism

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Omeprazole / Peptic Ulcer Hemorrhage / Enzyme Inhibitors / Anti-Ulcer Agents Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links